Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human DLD Antikörper:
anti-Mouse (Murine) DLD Antikörper:
anti-Rat (Rattus) DLD Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Cow (Bovine) Polyclonal DLD Primary Antibody für IHC, WB - ABIN2787688
Ayanniyi, Raji, Adegoke: Prevalence of asymptomatic sacroiliac joint dysfunction and its association with leg length discrepancies in male students in selected junior secondary schools in Ibadan. in African journal of medicine and medical sciences 2008
Show all 2 Pubmed References
Pig (Porcine) Polyclonal DLD Primary Antibody für IP, ELISA - ABIN4369742
Butler, Mishur, Bhaskaran, Rea: A metabolic signature for long life in the Caenorhabditis elegans Mit mutants. in Aging cell 2013
Human Monoclonal DLD Primary Antibody für IHC (p), ELISA - ABIN560607
Chan, Qian, Diamond, Liu, Gritsenko, Monroe, Camp, Smith, Katze: Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production. in Journal of virology 2007
Molecular characterization of dihydrolipoamide dehydrogenase binding sites to titanium dioxide has been reported.
study found that individuals infected with HBV withwith basal core promoter (BCP (zeige OPN1SW Antikörper)) double mutations (A1762T, G1764A)have lower concentrations of serum DLD than those with the wild-type BCP (zeige OPN1SW Antikörper)
Mitochondrial dihydrolipoamide dehydrogenase is upregulated in response to the brain intermittent hypoxic preconditioning.
IgA (zeige IgA Antikörper) autoantibody against DLD could be a novel diagnostic marker for endometrial cancer.
Case Report: novel mutation in the DLD interface giving rise to DLD deficiency.
Human, mouse, and pig Dld has moonlighting function as a protease in addition to its canonical function as a a dehydrogenase.
This molecular dynamics study proposes the structural changes that may lead to the modulation in reactive oxygen species generation by pathogenic mutants of human dihydrolipoamide dehydrogenase.
the cryptic activities of DLD promote oxidative damage to neighboring molecules and thus contribute to the clinical severity of DLD mutations
Structural and thermodynamic basis for weak interactions between dihydrolipoamide dehydrogenase and subunit-binding domain of the branched-chain alpha-ketoacid dehydrogenase complex.
the E3 binding protein (zeige PDHX Antikörper) component of the pyruvate dehydrogenase (zeige PDP Antikörper) complex appear to be a rare cause of pyruvate dehydrogenase (zeige PDP Antikörper) deficiency
DLD, malic acid, and fumaric acid can be used for development of cosmeceuticals and nutraceuticals regulating the change of skin metabolism induced by the UVB overexposure.
Data show that mitochondrial diaphorases (dihydrolipoamide dehydrogenase) in the liver contribute up to 81% to the NAD(+) pool during respiratory inhibition.
Mice that are deficient in dihydrolipoamide dehydrogenase show increased vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP (zeige PTPN2 Antikörper)), malonate and 3-nitropropionic acid, which have been used in models of Parkinson disease and Huntington disease (zeige HTT Antikörper)
These findings show that the plastidial LIPOAMIDE DEHYDROGENASE, ptLPD, isoforms are critical in vivo determinants of arsenite-mediated arsenic sensitivity in Arabidopsis and possible strategic targets for increasing arsenic tolerance. [ptLPD2]
Lipoamide dehydrogenase significantly accelerates the conversion of a defined subset of NO donors to NO.
This gene encodes the L protein of the mitochondrial glycine cleavage system. The L protein, also named dihydrolipoamide dehydrogenase, is also a component of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acide dehydrogenase complex. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency.
E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex, branched chain keto acid dehydrogenase complex
, dihydrolipoyl dehydrogenase, mitochondrial
, glycine cleavage system L protein
, glycine cleavage system protein L
, lipoamide dehydrogenase
, lipoamide reductase
, lipoyl dehydrogenase
, branched chain alpha-keto acid dehydrogenase complex subunit E3
, dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex, branched chain keto acid dehydrogenase complex)
, dihydrolipoamide dehydrogenase
, dihydrolipoyl dehydrogenase
, protein BfmBC
, dihydrolipoamide:NAD oxidoreductase
, glycine cleavage system L-protein
, dihydrolipoamide: NAD+ oxidoreductase
, Dihydrolipoyl dehydrogenase, mitochondrial